**Core Concept**
Upshaw-Schulman syndrome is a rare genetic disorder characterized by a deficiency of the von Willebrand factor-cleaving protease, also known as ADAMTS13. This enzyme plays a crucial role in regulating von Willebrand factor (VWF) levels in the blood, which is essential for blood clotting.

**Why the Correct Answer is Right**
The deficiency of ADAMTS13 leads to the accumulation of ultra-large VWF multimers, which are highly thrombogenic. This results in the development of thrombotic thrombocytopenic purpura (TTP), a condition characterized by the formation of blood clots in small blood vessels throughout the body. The clots can lead to a decrease in platelet count, renal failure, and neurological symptoms.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because Upshaw-Schulman syndrome is not caused by a deficiency of von Willebrand factor (VWF) itself, but rather by a deficiency of the enzyme responsible for cleaving VWF.
**Option B:** This option is incorrect because hemophilia A is caused by a deficiency of factor VIII, not ADAMTS13 or VWF.
**Option C:** This option is incorrect because Bernard-Soulier syndrome is caused by a deficiency of platelet glycoproteins, not ADAMTS13 or VWF.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that Upshaw-Schulman syndrome is often misdiagnosed as hemolytic uremic syndrome (HUS), as both conditions present with thrombocytopenia, microangiopathic hemolytic anemia, and renal failure. However, TTP is typically associated with neurological symptoms and a more severe clinical course.

**Correct Answer: D.**